Studies have shown that higher CRP-to-albumin ratios are associated with relatively worse prognosis from early-stage to metastatic cancers, and across all types, including genitourinary, gastrointestinal, lung, and breast cancers 18-23. Here, ALB is linked to breast carcinoma.